Manning & Napier Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Manning & Napier Advisors's LLY Position: Q2 2026 in Review
Manning & Napier Advisors increased its Eli Lilly (LLY) stake by 311% in Q2 2026, buying an estimated $143K and bringing the position to 185 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #321.
Manning & Napier Advisors first reported a position in LLY in Q2 2013 and has held it in 23 quarters since. The position peaked at $382M in Q2 2015. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Manning & Napier Advisors held 185 shares of Eli Lilly worth $227K as of Q2 2026.
- Manning & Napier Advisors bought 140 Eli Lilly shares in Q2 2026, an estimated $143K.
- Eli Lilly made up ﹤0.01% of Manning & Napier Advisors's portfolio in Q2 2026, its #321 holding.
- Manning & Napier Advisors first reported a position in Eli Lilly in Q2 2013 and has held it in 23 quarters since.
- Manning & Napier Advisors's Eli Lilly position peaked at $382M in Q2 2015.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Manning & Napier Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.